InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Deshpande Milind. Officer active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 3 disclosures have been published. History available since 15 September 2022. The latest transaction was filed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations